SSAB participating in EU project to promote hydrogen gas in industry
CSP
3 min read
9

SSAB participating in EU project to promote hydrogen gas in industry

January 21, 2025
0

Reading Time: 2 minutes TWINGHY, a project co-funded by the EU, mainly aims to introduce hydrogen as a fuel to replace natural gas in reheating furnaces in the steel sector. The project will develop a digital twin to control furnace behavior and optimize operations. The technology

Continue Reading
CSP
3 min read
9

South Korea to grant precision medicine patent to Diamyd Medical for insulin antigen treatment in autoimmune diabetes

January 21, 2025
0

Reading Time: 2 minutes The South Korean Patent Office will grant a patent protecting the use of insulin-based antigens for the treatment of autoimmune diabetes in patients with the HLA DR4-DQ8 genetic marker. This patent, valid until 2035, marks South Korea as the first country globally

Continue Reading
CSP
1 min read
7

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

January 21, 2025
0

Reading Time: < 1 minute ANNOUNCEMENT NO. 18 – 21 JANUARY 2025   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements

Continue Reading
Summa Defence’s subsidiary Uudenkaupungin Työvene and Baltic Workboats receive 110 million euro vessel order from Belgium
CSP
3 min read
5

Summa Defence’s subsidiary Uudenkaupungin Työvene and Baltic Workboats receive 110 million euro vessel order from Belgium

January 21, 2025
0

Reading Time: 3 minutes Summa Defence Ltd                                                        Press release, free for publication on 21.1.2025 at 10:00 EET Defense and security technology group Summa Defence’s subsidiary Uudenkaupungin Työvene and Baltic Workboats have signed a 110 million euro shipbuilding contract with the Belgian government. Uudenkaupungin Työvene and

Continue Reading
World’s largest bulk export port authority chooses two Konecranes Gottwald Mobile Harbor Cranes to boost lifting capacity
CSP
3 min read
6

World’s largest bulk export port authority chooses two Konecranes Gottwald Mobile Harbor Cranes to boost lifting capacity

January 21, 2025
0

Reading Time: 3 minutes Pilbara Ports in Western Australia has ordered two ESP.9 Konecranes Gottwald Mobile Harbor Cranes for the Port of Port Hedland – the world’s largest bulk export port by tonnage. The cranes were booked in Q4 2024 and are scheduled to

Continue Reading
CSP
2 min read
9

Nordea cancels repurchased shares – Nordea

January 21, 2025
0

Reading Time: < 1 minute Nordea Bank Abp Stock exchange release – Total number of voting rights and capital 21 January 2025 at 9.15 EET Nordea has today cancelled 4,841,641 treasury shares in line with the decision by the Board of Directors. The shares were

Continue Reading
CSP
1 min read
4

Elisa: Q4 Interim Report and Financial Statements Release 2024 publication on 31 January 2025

January 21, 2025
0

Reading Time: < 1 minute ELISA CORPORATION INVESTOR NEWS 21 JANUARY 2025 AT 8:30 AM Elisa will publish its Q4 2024 Interim Report and Financial Statements Release 2024 on Friday 31 January 2025 at approximately 8:30 am EET (6:30 am UK time). An international conference call for analysts

Continue Reading
CSP
3 min read
5

Halton Group accelerates climate action by committing to set science-based targets

January 21, 2025
0

Reading Time: 2 minutes Halton, a global technology leader in demanding indoor air solutions commits to set a near-term science-based target as well as a net zero target aligned with the requirements of the Science-Based Targets initiative (SBTi). Halton’s commitment includes reducing its Scope 1 and

Continue Reading
First patients treated in Neogap Therapeutics’ personalised immunotherapy trial
CSP
3 min read
6

First patients treated in Neogap Therapeutics’ personalised immunotherapy trial

January 21, 2025
0

Reading Time: 3 minutes Neogap Therapeutics AB, a Swedish biotechnology company developing personalised immunotherapy for cancer treatment, announces that the first two patients have been treated in the company’s Phase I/II clinical trial. The trial investigates the safety and tolerability of a new, tailored treatment for

Continue Reading
Steeve Lavoie takes over as new CEO of SEGULA Technologies Canada
CSP
2 min read
6

Steeve Lavoie takes over as new CEO of SEGULA Technologies Canada

January 20, 2025
0

Reading Time: 2 minutes   PRESS RELEASE 20 January 2024     APPOINTMENT   Global engineering group SEGULA Technologies announces the appointment of Steeve Lavoie as President and CEO of SEGULA Technologies Canada. This appointment marks a key step in SEGULA Technologies’ exceptional growth in

Continue Reading